RGDI Promotes Drug Discovery
With effective therapies for rare diseases being hard to come by, how can drug development be accelerated? Better collaborative relationships among patients, researchers, medical professionals and commercial partners may be the key. Rare Genomics Institute is seeking to leverage its resources to help bring about such collaborations. A specialized project team, the Rare Genomics Drug Initiative (RGDI), has been formed to promote the development of new drugs and therapeutic approaches to benefit rare disease patients. The team aims to advance the discovery of drugs for rare disorders with limited therapeutic options by addressing patient needs with a strong foundation of knowledge and strategic partnerships.